Dose-response relationship of tetronasin administered to grazing steers

Two grazing experiments were conducted to evaluate the dose-response relationship of steers to the ionophore tetronasin. Bermudagrass-based pastures were grazed 126 d in Exp. 1, and annual ryegrass or an annual ryegrass-berseem clover mixture was grazed 112 d in Exp. 2. Tetronasin was administered i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of animal science 1989-12, Vol.67 (12), p.3419-3424
Hauptverfasser: Gates, R.N. (USDA-ARS, Coastal Plain Exp. Sta., Tifton, GA), Roland, L.T, Wyatt, W.E, Hembry, F.G, Bailie, J.H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Two grazing experiments were conducted to evaluate the dose-response relationship of steers to the ionophore tetronasin. Bermudagrass-based pastures were grazed 126 d in Exp. 1, and annual ryegrass or an annual ryegrass-berseem clover mixture was grazed 112 d in Exp. 2. Tetronasin was administered in ground corn (.91 kg/hd) fed daily to provide dosages of 0, 7.5, 15, 30, 60 or 90 mg. One hundred forty-four steers (220 kg, Exp. 1; 196 kg, Exp. 2) were allocated to treatment groups of six steers within four initial weight blocks in Exp. 1 and within two initial weight blocks, assigned to two forage types in Exp. 2. Initial weight blocks were confounded with four pasture blocks, divided in six 1.35-ha paddocks. Treatment groups were rotated among paddocks within pasture block every 2 wk. Stepwise tetronasin addition resulted in a linear increase (P less than .05) in the proportion of propionic acid and a linear decrease (P less than .05) in the proportion of acetic acid and the acetic to propionic acid ratio in both experiments. Total VFA concentrations were not altered in Exp. 1 but they decreased linearly in Exp. 2 with tetronasin addition. Maximal observed improvement in daily gain (.1 kg) occurred at a dosage of 30 mg.hd-1.d-1 in Exp. 1 and 90 mg.hd-1.d-1 in Exp. 2. Daily gain increased linearly (P less than .06) with tetronasin level in both experiments.
ISSN:0021-8812
1525-3163
0021-8812
DOI:10.2527/jas1989.67123419x